123 related articles for article (PubMed ID: 17555310)
1. Automated pharmacophore query optimization with genetic algorithms - a case study using the MC4R system.
Jia L; Zou J; So SS; Sun H
J Chem Inf Model; 2007; 47(4):1545-52. PubMed ID: 17555310
[TBL] [Abstract][Full Text] [Related]
2. A predictive pharmacophore model of human melanocortin-4 receptor as derived from the solution structures of cyclic peptides.
Sun H; Greeley DN; Chu XJ; Cheung A; Danho W; Swistok J; Wang Y; Zhao C; Chen L; Fry DC
Bioorg Med Chem; 2004 May; 12(10):2671-7. PubMed ID: 15110848
[TBL] [Abstract][Full Text] [Related]
3. LEAP into the Pfizer Global Virtual Library (PGVL) space: creation of readily synthesizable design ideas automatically.
Hu Q; Peng Z; Kostrowicki J; Kuki A
Methods Mol Biol; 2011; 685():253-76. PubMed ID: 20981528
[TBL] [Abstract][Full Text] [Related]
4. SeleX-CS: a new consensus scoring algorithm for hit discovery and lead optimization.
Bar-Haim S; Aharon A; Ben-Moshe T; Marantz Y; Senderowitz H
J Chem Inf Model; 2009 Mar; 49(3):623-33. PubMed ID: 19231809
[TBL] [Abstract][Full Text] [Related]
5. Enhancing specificity and sensitivity of pharmacophore-based virtual screening by incorporating chemical and shape features--a case study of HIV protease inhibitors.
Pandit D; So SS; Sun H
J Chem Inf Model; 2006; 46(3):1236-44. PubMed ID: 16711743
[TBL] [Abstract][Full Text] [Related]
6. Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms.
Xiang Z; Pogozheva ID; Sorenson NB; Wilczynski AM; Holder JR; Litherland SA; Millard WJ; Mosberg HI; Haskell-Luevano C
Biochemistry; 2007 Jul; 46(28):8273-87. PubMed ID: 17590021
[TBL] [Abstract][Full Text] [Related]
7. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization.
Hartenfeller M; Proschak E; Schüller A; Schneider G
Chem Biol Drug Des; 2008 Jul; 72(1):16-26. PubMed ID: 18564216
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening of cathepsin k inhibitors using docking and pharmacophore models.
Ravikumar M; Pavan S; Bairy S; Pramod AB; Sumakanth M; Kishore M; Sumithra T
Chem Biol Drug Des; 2008 Jul; 72(1):79-90. PubMed ID: 18498326
[TBL] [Abstract][Full Text] [Related]
9. Critical comparison of virtual screening methods against the MUV data set.
Tiikkainen P; Markt P; Wolber G; Kirchmair J; Distinto S; Poso A; Kallioniemi O
J Chem Inf Model; 2009 Oct; 49(10):2168-78. PubMed ID: 19799417
[TBL] [Abstract][Full Text] [Related]
10. Chemical function-based pharmacophore development for novel, selective kappa opioid receptor agonists.
Singh N; Nolan TL; McCurdy CR
J Mol Graph Model; 2008 Sep; 27(2):131-9. PubMed ID: 18456526
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening strategies in drug discovery.
McInnes C
Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
[TBL] [Abstract][Full Text] [Related]
12. Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation.
Askjaer S; Langgård M
J Chem Inf Model; 2008 Mar; 48(3):476-88. PubMed ID: 18281962
[TBL] [Abstract][Full Text] [Related]
13. Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2.
Zou J; Xie HZ; Yang SY; Chen JJ; Ren JX; Wei YQ
J Mol Graph Model; 2008 Nov; 27(4):430-8. PubMed ID: 18786843
[TBL] [Abstract][Full Text] [Related]
14. Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.
Franke L; Schwarz O; Müller-Kuhrt L; Hoernig C; Fischer L; George S; Tanrikulu Y; Schneider P; Werz O; Steinhilber D; Schneider G
J Med Chem; 2007 May; 50(11):2640-6. PubMed ID: 17461565
[TBL] [Abstract][Full Text] [Related]
15. Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques.
Ebalunode JO; Ouyang Z; Liang J; Zheng W
J Chem Inf Model; 2008 Apr; 48(4):889-901. PubMed ID: 18396858
[TBL] [Abstract][Full Text] [Related]
16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 1-amino-4-phenylcyclohexane-1-carboxylic acid and its influence on agonist selectivity between human melanocortin-4 and -1 receptors in linear pentapeptides.
Chu XJ; Bartkovitz D; Danho W; Swistok J; Cheung AW; Kurylko G; Rowan K; Yeon M; Franco L; Qi L; Chen L; Yagaloff K
Bioorg Med Chem Lett; 2005 Nov; 15(22):4910-4. PubMed ID: 16169218
[TBL] [Abstract][Full Text] [Related]
18. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
Klabunde T; Giegerich C; Evers A
J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
[TBL] [Abstract][Full Text] [Related]
19. Flux (2): comparison of molecular mutation and crossover operators for ligand-based de novo design.
Fechner U; Schneider G
J Chem Inf Model; 2007; 47(2):656-67. PubMed ID: 17315990
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel mGluR1 antagonists: a multistep virtual screening approach based on an SVM model and a pharmacophore hypothesis significantly increases the hit rate and enrichment factor.
Li GB; Yang LL; Feng S; Zhou JP; Huang Q; Xie HZ; Li LL; Yang SY
Bioorg Med Chem Lett; 2011 Mar; 21(6):1736-40. PubMed ID: 21316965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
